Sandoz Group (OTCMKTS:SDZNY) Shares Gap Up – Time to Buy?

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $85.80, but opened at $89.85. Sandoz Group shares last traded at $89.30, with a volume of 1,912 shares traded.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on SDZNY shares. Royal Bank Of Canada cut Sandoz Group from a “moderate buy” rating to a “hold” rating in a research note on Monday, March 23rd. Barclays raised Sandoz Group from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 5th. Finally, The Goldman Sachs Group raised Sandoz Group to a “strong-buy” rating in a research report on Wednesday, April 1st. Three research analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Strong Buy”.

Sandoz Group Stock Up 1.5%

The firm has a 50-day moving average price of $83.32 and a 200-day moving average price of $80.34. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.18 and a quick ratio of 0.77.

About Sandoz Group

Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.

The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.